These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 4748553)

  • 41. Amphetamine toxicity: behavioral and neuropathological indexes.
    Schuster CR; Fischman MW
    Fed Proc; 1975 Aug; 34(9):1845-51. PubMed ID: 1097269
    [No Abstract]   [Full Text] [Related]  

  • 42. Repeated acquisition as a behavioral base line for studying drug effects.
    Thompson DM
    J Pharmacol Exp Ther; 1973 Feb; 184(2):506-14. PubMed ID: 4688186
    [No Abstract]   [Full Text] [Related]  

  • 43. Amphetamine-induced taste aversion: a comparison of d- versus l-amphetamine.
    Carey RJ; Goodall EB
    Pharmacol Biochem Behav; 1974 May; 2(3):325-30. PubMed ID: 4837904
    [No Abstract]   [Full Text] [Related]  

  • 44. Behavioral characterization of d- and l-amphetamine: neurochemical implications.
    Segal DS
    Science; 1975 Oct; 190(4213):475-7. PubMed ID: 1166317
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Scratching response induced in mice by mescaline and related amphetamine derivatives.
    Kulkarni AS
    Biol Psychiatry; 1973 Apr; 6(2):177-80. PubMed ID: 4709133
    [No Abstract]   [Full Text] [Related]  

  • 46. Effect of amphetamine on sequences of behavioural activities in mice.
    Krsiak M; Pribík V
    Act Nerv Super (Praha); 1978 Feb; 20(1):9-11. PubMed ID: 565125
    [No Abstract]   [Full Text] [Related]  

  • 47. EEG and behavioral effects of 2-5-methoxy-4-methyl-amphetamine (DOM, STP).
    Florio V; Lipparini F; Scotti de Carolis A; Longo VG
    Arch Int Pharmacodyn Ther; 1969 Jul; 180(1):81-8. PubMed ID: 5357012
    [No Abstract]   [Full Text] [Related]  

  • 48. Behavioural specific tolerance following chronic d- or l-amphetamine treatment: lack of involvement of p-hydroxynorephedrine.
    Kokkinidis L; Anisman H
    Neuropharmacology; 1978 Feb; 17(2):95-102. PubMed ID: 634452
    [No Abstract]   [Full Text] [Related]  

  • 49. Schedule-controlled behaviors as determinants of drug response.
    Morse WH
    Fed Proc; 1975 Aug; 34(9):1868-9. PubMed ID: 1149895
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differentiation of pressor and behavioral effects of d-amphetamine and 2,5-dimethoxy-4-methylamphetamine (STP) by cinanserin.
    Huang JT; Ho BT
    Can J Physiol Pharmacol; 1973 Dec; 51(12):976-80. PubMed ID: 4777246
    [No Abstract]   [Full Text] [Related]  

  • 51. d-Amphetamine-chlorpromazine antagonism in a food reinforced operant.
    BROWN H
    J Exp Anal Behav; 1963 Jul; 6(3):395-8. PubMed ID: 14015971
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhibition of rat predatory aggression by acute and chronic D- and L-amphetamine.
    Barr GA; Gibbons JL; Bridger WH
    Brain Res; 1977 Apr; 124(3):565-70. PubMed ID: 558035
    [No Abstract]   [Full Text] [Related]  

  • 53. An analysis of behavioural mechanisms involved in the acquisition of amphetamine anorectic tolerance.
    Demellweek C; Goudie AJ
    Psychopharmacology (Berl); 1983; 79(1):58-66. PubMed ID: 6403966
    [No Abstract]   [Full Text] [Related]  

  • 54. Discriminative response control by d-amphetamine and related compounds in the rat.
    Jones CN; Hill HF; Harris RT
    Psychopharmacologia; 1974 May; 36(4):347-56. PubMed ID: 4152601
    [No Abstract]   [Full Text] [Related]  

  • 55. Prior drug experience and effects of amphetamine on schedule controlled behavior.
    Tilson HA; Rech RH
    Pharmacol Biochem Behav; 1973; 1(1):129-32. PubMed ID: 4775579
    [No Abstract]   [Full Text] [Related]  

  • 56. Interactions between carbon monoxide and d-amphetamine or pentobarbital on schedule-controlled behavior.
    McMillan DE; Miller AT
    Environ Res; 1974 Aug; 8(1):53-63. PubMed ID: 4455498
    [No Abstract]   [Full Text] [Related]  

  • 57. A study of the interaction between amphetamine and food deprivation.
    Simpson LL
    Psychopharmacologia; 1974; 38(4):279-86. PubMed ID: 4427983
    [No Abstract]   [Full Text] [Related]  

  • 58. Paradoxical effects of low doses of d-amphetamine in rats.
    Glick SD; Muller RU
    Psychopharmacologia; 1971; 22(4):396-402. PubMed ID: 5133440
    [No Abstract]   [Full Text] [Related]  

  • 59. In vitro inhibition of monoamine oxidase types A and B by d- and l-amphetamine.
    Miller HH; Clarke DE
    Commun Psychopharmacol; 1978; 2(4):319-25. PubMed ID: 729356
    [No Abstract]   [Full Text] [Related]  

  • 60. Quantitative recording of turning behaviour induced or potentiated by amphetamine after unilateral brain lesions in the rat.
    Szabó I; Németh L
    Acta Physiol Acad Sci Hung; 1974; 45(3-4):287-92. PubMed ID: 4471273
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.